Chemical Compound
Brimonidine tartarate; Brimonidine D-tartrate; Brimonidine Tartrate; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (2R,3R)-2,3-dihydroxybutanedioate (1:1); 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); AGN 190342LF; Alphagan; Alphagan P; Brimonidine Purite; Brimonidine tartrate; Brominide tartrate
CAS Registry Number
70359-46-5
Primary record
Brimonidine tartarate; Brimonidine D-tartrate; Brimonidine Tartrate; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (2R,3R)-2,3-dihydroxybutanedioate (1:1); 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); AGN 190342LF; Alphagan; Alphagan P; Brimonidine Purite; Brimonidine tartrate; Brominide tartrate
- 库存
- 4,583 克
- 纯度
- 98.2 %
- CAS
- 70359-46-5
化合物标识与属性
- CAS
- 70359-46-5
- PubChem CID
- 54405
- SMILES
- C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- Canonical SMILES
- Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)[C@H](O)[C@@H](O)C(=O)O
名称与同义词
- BRIMONIDINE TARTRATE
- Alphagan
- Brimonidine tartarate
- brimonidine
- mirvaso
- Brominide tartrate
- Qoliana
- Alphagan P
- Lumify
- 70359-46-5
- Brimonidine D-tartrate
- Brimonidine L-Tartrate
- Brymont
- Bromoxidine tartrate
- brimonidine Purite
- Alphagan-P
- Ratio Brimonidine
- Alphagan (TN)
- Brimonidine (tartrate)
- Brimonidinne tartrate
- Brimonidine D-tartarate
- 5-bromo-N-
- Brimonidine-D-tartrate
- 4S9CL2DY2H
- Brimonidine tartrate [USAN]
- RefChem:58238
- UNII-4S9CL2DY2H
- Brimonidine tartrate CRS
- AC1L1GYC
- OCU300
- UK 14,304 tartrate
- AGN 190342-LF
- AGN-190342-LF
- C11H10BrN5.C4H6O6
- D00ARM
- AC1Q59OR
- OCU-300
- AGN-190342LF
- MFCD07773072
- C15H16BrN5O6
- AGN 190342LF
- Brimonidine tartrate [USAN:JAN]
- DTXSID70911371
- Cd-07805
- HY-B0659AR
- orb1300783
- CHEMBL1200389
- SCHEMBL29378438
- CHEBI:51157
- EX-A5415A
- HY-B0659A
- UK-14304-18
- Brimonidine tartrate (JAN/USAN)
- QZHBYNSSDLTCRG-LREBCSMRSA-N
- Brimonidine (tartrate) (Standard)
- BRIMONIDINE TARTRATE [JAN]
- DTXCID501340408
- GLXC-07935
- HMS3715P18
- LUMIFY Redness Reliever Eye Drops
- ACT08633
- BRIMONIDINE D-TARTRATE [MI]
- CID54405
- EBD23481
- KS-00000K6V
- BRIMONIDINE TARTRATE [VANDF]
- AGN190342
- BRIMONIDINE TARTRATE [MART.]
- MFCD00153878
- BRIMONIDINE TARTRATE [USP-RS]
- BRIMONIDINE TARTRATE [WHO-DD]
- CD07805/47
- UK-1430418
- AKOS016845265
- CD-07805/47
- AGN-190342
- CCG-221278
- CS-4496
- CS-O-03921
- FB32174
- L(+)-TARTARIC ACID; BRIMONIDINE
- AN-12800
- AS-18083
- BRIMONIDINE TARTRATE [ORANGE BOOK]
- C11-H10-Br-N5.C4-H6-O6
- LUMIFY PRESERVATIVE FREE EYE DROPS
- SY065942
- UK14,308
- BRIMONIDINE TARTRATE [EP MONOGRAPH]
- SIMBRINZA COMPONENT BRIMONIDINE TARTRATE
- AB0021226
- BRIMONIDINE TARTRATE [USP MONOGRAPH]
- LS-177484
- UK 14,308
- UK-14,308
- 5-bromo-6-(imidazolin-2-ylamino)quinoxaline
- ST24046243
- UK14,30418
- W0014
- YUVEZZI COMPONENT BRIMONIDINE TARTRATE
- 79570-19-7
- COMBIGAN COMPONENT BRIMONIDINE TARTRATE
- UK 14,30418
- 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline
- 5-bromo-6-(imidazolidinylideneamino)quinoxaline
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
- A13433
- A19740
- D02076
- UK 14,304 18
- UK-14,304-18
- Brimonidine Tartrate ophthalmic solution, 0.15%
- Brimonidine tartrate, 98.5% - 100MG 100mg
- 359B465
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxysuccinate
- 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate (1:1)
- brimonidine tartrate (1:1), (S-(R*,R*))-isomer
- 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- 5-bromo-6-(2-imidazolin-2-ylamino)quinoxaline d-tartrate
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate
- B0084-075609
- (2R,3R)-2,3-dihydroxybutanedioic acid; 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- (4,5-Bihydro-1H-imidazol-2-yl)quinoxalin-6-amine L-tartrate
- (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1h-imidazol-2-yl)-amine L-tartrate
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine(2R,3R)-2,3-dihydroxysuccinate
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) quinoxalin-6-amine tartrate
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine L-Tartrate
- 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine D-tartrate
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine; (2R,3R)-2,3-dihydroxybutanedioic acid
- 59803-98-4
- 59803-99-5
- 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
- BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8%
- (2R,3R)-2,3-Dihydroxybutanedioic acid--5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (1/1)
- 109826-56-4
- 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
- 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1)
- 6-Quinoxalinamine, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate(1:1)
- 629-848-5
- Brimonidine tartarate; Brimonidine D-tartrate; Brimonidine Tartrate; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine (2R,3R)-2,3-dihydroxybutanedioate (1:1); 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1); AGN 190342LF; Alphagan; Alphagan P; Brimonidine Purite; Brimonidine tartrate; Brominide tartrate